Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - PROTO SCRIPT PHARMACEUTICAL CORPFinancial_Report.xls
EX-31.1 - EXHIBIT 31.1 - PROTO SCRIPT PHARMACEUTICAL CORPexhibit311.htm
10-K - FORM 10-K - PROTO SCRIPT PHARMACEUTICAL CORPf002yanex10kmay312012draft2.htm


CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


I, Gustavo G. Sune, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:


(1)

the Annual Report on Form 10-K of Yanex Group, Inc. for the year ended May 31, 2012 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


(2)

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Intervia Inc.


Dated:  September 13, 2012

 

 

 

/s/ Gustavo G. Sune                          

 

Gustavo G. Sune

President, Chief Executive Officer, Chief Financial Officer, Treasurer and Director

(Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer)